IONCTURA
iOnctura is a biopharmaceutical company focusing on novel therapeutics to modulate key culprits of immunosuppression in the tumor microenvironment. Immune checkpoint inhibitors (eg PD/PD-L1) have shown remarkable effectiveness for some but not for all cancer patients. The company aims to improve current immune checkpoint therapies by developing novel drugs with potential safety and efficacy profiles that when combined with checkpoint inhibition have the potential to optimize clinical outcomes.... Through its partnerships with Merck and Cancer Research Technology (the commercial arm of Cancer Research UK, London, UK), iOnctura has established a pipeline of preclinical molecules to advance towards the clinic in combination with immuno-oncology assets from Merck. iOnctura is supported by a world renowned scientific advisory board and, with its access to CRT’s drug discovery labs and network of academic collaborators, is well-positioned to rapidly establish novel combination therapies in the field of cancer immunology.
IONCTURA
Industry:
Biotechnology Health Care Medical Device
Founded:
2017-06-01
Address:
Genève, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.ionctura.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
22.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Apache Global Site Tag
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Investors List
M Ventures
M Ventures investment in Series A - iOnctura
Inkef
Inkef investment in Series A - iOnctura
3B Future Health Fund
3B Future Health Fund investment in Series A - iOnctura
VI Partners
VI Partners investment in Series A - iOnctura
Schroder Adveq
Schroder Adveq investment in Series A - iOnctura
Schroder Adveq
Schroder Adveq investment in Series A - iOnctura
VI Partners
VI Partners investment in Series A - iOnctura
M Ventures
M Ventures investment in Series A - iOnctura
Inkef
Inkef investment in Series A - iOnctura
M Ventures
M Ventures investment in Seed Round - iOnctura
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-05 | iOnctura Strengthens Management With Appointment of Sean A. MacDonald as Chief Business Officer |
Official Site Inspections
http://www.ionctura.com Semrush global rank: 7.87 M Semrush visits lastest month: 420
- Host name: afc32dd100992fdcc.awsglobalaccelerator.com
- IP address: 15.197.165.181
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
